These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35703766)

  • 21. Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women.
    Dauria EF; Levine A; Hill SV; Tolou-Shams M; Christopoulos K
    Arch Sex Behav; 2021 May; 50(4):1743-1754. PubMed ID: 33236275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
    Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
    J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-Exposure Prophylaxis Care Continuum, Barriers, and Facilitators among Black Men Who Have Sex with Men in the United States: A Systematic Review and Meta-Analysis.
    Russ S; Zhang C; Liu Y
    AIDS Behav; 2021 Jul; 25(7):2278-2288. PubMed ID: 33438151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Role of Provider-Patient Communication in Women's Sexual Health and Pre-Exposure Prophylaxis Care in the Primary Care Settings in New York State of the United States.
    Zhang C; Fiscella K; Liu Y
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods.
    Merle JL; Zapata JP; Quieroz A; Zamantakis A; Sanuade O; Mustanski B; Smith JD
    Addict Sci Clin Pract; 2024 May; 19(1):46. PubMed ID: 38816889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.
    Walters SM; Platt J; Anakaraonye A; Golub SA; Cunningham CO; Norton BL; Sevelius JM; Blackstock OJ
    AIDS Behav; 2021 Dec; 25(12):3987-3999. PubMed ID: 34138377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review.
    Glick JL; Russo R; Jivapong B; Rosman L; Pelaez D; Footer KHA; Sherman SG
    AIDS Behav; 2020 May; 24(5):1312-1333. PubMed ID: 31807973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PrEP Care Continuum and Black Men Who Have Sex with Men: A Scoping Review of Published Data on Awareness, Uptake, Adherence, and Retention in PrEP Care.
    Ezennia O; Geter A; Smith DK
    AIDS Behav; 2019 Oct; 23(10):2654-2673. PubMed ID: 31463711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability and Appropriateness of Digital PrEP Interventions for Black and Latina Cisgender Women: Perspectives From Service Providers in Los Angeles County.
    Üsküp DK; Nieto O; Rosenberg-Carlson E; Lee SJ; Milburn NG; Brooks RA
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S134-S140. PubMed ID: 35703765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States.
    Clement ME; Johnston BE; Eagle C; Taylor D; Rosengren AL; Goldstein BA; Seña AC
    AIDS Patient Care STDS; 2019 Aug; 33(8):366-371. PubMed ID: 31233329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    Li DH; Benbow N; Keiser B; Mongrella M; Ortiz K; Villamar J; Gallo C; Deskins JS; Xavier Hall CD; Miller C; Mustanski B; Smith JD
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S235-S246. PubMed ID: 35703776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers and Facilitators to Pre-exposure Prophylaxis Uptake Among Black Women: A Qualitative Analysis Guided by a Socioecological Model.
    D'Angelo AB; Davis Ewart LN; Koken J; Bimbi D; Brown JT; Grov C
    J Assoc Nurses AIDS Care; 2021 Jul-Aug 01; 32(4):481-494. PubMed ID: 34171885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community perspectives on addressing and responding to HIV-testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) among African, Caribbean and Black (ACB) people in Ontario, Canada.
    Etowa J; Tharao W; Mbuagbaw L; Baidoobonso S; Hyman I; Obiorah S; Aden M; Etowa EB; Gebremeskel A; Kihembo M; Nelson L; Husbands W
    BMC Public Health; 2022 May; 22(1):913. PubMed ID: 35525946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
    Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
    AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP).
    Kaul CM; Moore BE; Kaplan-Lewis E; Casey E; Pitts RA; Pagan Pirallo P; Lim S; Kapadia F; Cohen GM; Khan M; Mgbako O
    PLoS One; 2023; 18(9):e0291657. PubMed ID: 37725628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social and structural factors associated with interest in HIV preexposure prophylaxis among Black women in the United States.
    Irie WC; Calabrese SK; Mayer KH; Geng EH; Blackstock O; Marcus JL
    AIDS Care; 2024 May; 36(5):672-681. PubMed ID: 38176016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Qualitative Exploration of PrEP Interests, Barriers, and Interventions Among Black and Latina Cisgender Women in the U.S.
    Nydegger LA; Kidane H; Benitez S; Yuan M; Claborn KR
    Arch Sex Behav; 2024 Feb; 53(2):771-783. PubMed ID: 37796358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provider Comfort with Prescribing HIV Pre-Exposure Prophylaxis to Adolescents.
    Pina P; Taggart T; Sanchez Acosta M; Eweka I; Muñoz-Laboy M; Albritton T
    AIDS Patient Care STDS; 2021 Oct; 35(10):411-417. PubMed ID: 34623888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.